Prediction tools and risk stratification in epilepsy surgery.


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
07 Dec 2023
Historique:
revised: 03 12 2023
received: 08 08 2023
accepted: 05 12 2023
medline: 7 12 2023
pubmed: 7 12 2023
entrez: 7 12 2023
Statut: aheadofprint

Résumé

To conduct external validation of previously published epilepsy surgery prediction tools using a large independent multicenter dataset and to assess whether these tools can stratify patients for being operated and for becoming free of disabling seizures (ILAE 1 and 2). We analyzed a dataset of 1,562 patients, not used for tool development. We applied two scales: Epilepsy Surgery Grading Scale (ESGS) and Seizure Freedom Score (SFS), and two versions of Epilepsy Surgery Nomograms (ESNs): the original version and the modified version which included EEG data. For the ESNs we used calibration curves and concordance indexes. We stratified the patients into three tiers, for assessing the chances of attaining freedom of disabling seizures after surgery: high (ESGS 1, SFS 3-4, ESNs>70%), moderate (ESGS 2, SFS 2, ESNs 40-70%) and low (ESGS 2, SFS 0-1, ESNs<40%). We compared the three tiers as stratified by these tools, concerning the proportion of patients who were operated, and for the proportion of patients who became free of disabling seizures. The concordance indexes for the various versions of the nomograms were between 0.56 and 0.69. Both scales (ESGS, SFS) and nomograms accurately stratified the patients for becoming free of disabling seizures, with significant differences among the three tiers (p<0.05). In addition, ESGS and the modified ESN accurately stratified the patients for having been offered surgery, with significant difference among the three tiers (p<0.05). ESGS and the modified ESN (at thresholds of 40% and 70%) stratify patients undergoing presurgical evaluation into three tiers, with high, moderate and low chance for favorable outcome, with significant differences between the groups concerning having surgery and becoming free of disabling seizures. Stratifying patients for epilepsy surgery has the potential to help select the optimal candidates in underprivileged areas and better allocation of resources in developed countries.

Identifiants

pubmed: 38060351
doi: 10.1111/epi.17851
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

This article is protected by copyright. All rights reserved.

Auteurs

Levente Hadady (L)

Department of Neurology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.

Michael R Sperling (MR)

Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Juan Luis Alcala-Zermeno (JL)

Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Jacqueline A French (JA)

Department of Neurology, NYU Grossman School of Medicine, New York, New York, USA.

Patricia Dugan (P)

Department of Neurology, NYU Grossman School of Medicine, New York, New York, USA.

Lara Jehi (L)

Epilepsy Center, Cleveland Clinic, Cleveland, Ohio, USA.
Center for Computational Life Sciences, Cleveland, Ohio, USA.

Dániel Fabó (D)

Department of Neurology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
Department of Neurology, National Institute of Clinical Neurosciences, Budapest, Hungary.

Péter Klivényi (P)

Department of Neurology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.

Guido Rubboli (G)

Department of Neurology, Danish Epilepsy Center, Dianalund, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Sándor Beniczky (S)

Department of Neurology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
Department of Neurophysiology, Danish Epilepsy Center, Dianalund, Denmark.
Department of Clinical Medicine, Aarhus University and Department of Clinical Neurophysiology, Aarhus University Hoapital, Aarhus, Denmark.

Classifications MeSH